BRCA2 and cancer: As regards the association with overall cancer risk (Table 2), the OR of LOF variant carriers versus nonsynonymous variant carriers was 1.53 (95% CI: 0.80–2.92) and 1.14 (95% CI: 0.40–3.22) for BRCA1 and BRCA2, respectively.